Top Medtech Lobbyist Doubts Legislative Repercussions Of New Netflix Documentary
Executive Summary
AdvaMed's top lobbyist says a new documentary critical of the medical device industry and US FDA's device review pathways is unlikely to result in Congressional action. However, the group is talking to members on Capitol Hill to make sure they fully understand the context within which devices are reviewed and marketed.
You may also be interested in...
NuVasive Recalls Orthopedics Implants Over Biocompatibility Concerns
The US FDA says the company has voluntarily issued a recall for Precice metal implants after reports of adverse events that could be related to the design of the product or biocompatibility issues.
Into 2019: Digital Leads US Policy Innovations, But Public Medtech Scrutiny Grows
Scott Gottlieb's FDA continues to push out policy reforms and experiments at a rapid pace, with special focus on digital and AI technologies. In parallel, US Medicare officials are more publicly signaling plans to roll out policies for a quicker path to reimbursement for new devices. However, public scrutiny of whether device regulations properly protect patient safety is growing, and it could have an impact.
Device Sector Braces For Investigative Stories Critical Of Industry
AdvaMed has gotten wind over the past year that a major global investigative news consortium is planning to roll out a series of articles and broadcasts that are likely to be highly critical of the medical device industry. The group says it has been engaging with reporters in a push for balance.